The National Centre for Child Epilepsy
Pb. 53, Bærum Postterminal, 1306, Norway
NCT Number: NCT01278966
The purpose of the study is to evaluate the effect of the Modified Atkins Diet in children and adolescents with drug-resistant epilepsy regarding seizure control, and to create a protocol for the use of the Modified Atkins Diet as a treatment for epilepsy in Norway.
Looking for future studies?
Notify Me2 year–18 year
All sexes
Interventional
Not applicable
Pb. 53, Bærum Postterminal, 1306, Norway
The study is a prospective trial on the Modified Atkins Diet for children and adolescents with drug-resistant epilepsy. The Modified Atkins Diet is a less restrictive diet than the classical ketogenic diet, which is usually offered to this group of patients. Twenty patients between 2 and 18 years are included in the study, and the study period is 6 months. The study will be conducted at the National Centre for Child Epilepsy in Norway.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Modified Atkins Diet; 10 g carbohydrate per day and a high fat intake
Other names: Ketogenic diet
Time frame: 6 months
Seizure frequency is assessed after 1 month, 3 months and 6 months.
Time frame: After 6 months
24-hours EEG before diet treatment and after 6 months on the diet.
Time frame: 6 months
Body weight was measured before diet treatment, after 1 month, 3 months and 6 months.
Time frame: 6 months
Questionnaire assessing quality of life and life on a strict diet, assessed after one, three and six months.
Time frame: 6 months
Ketosis in blood and urine measured during the whole study period
Time frame: 10 weeks
3-days dietary records were obtained after two and ten weeks on the diet.
Oslo University Hospital
Other
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy - a Prospective Pilot Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06546410
Brain Diseases, Central Nervous System Diseases
Liverpool, United Kingdom
View Trial DetailsNCT07689084
Brain Diseases, Central Nervous System Diseases
Marburg, Hesse, Germany
View Trial DetailsNCT07689617
Brain Diseases, Central Nervous System Diseases
Elâzığ, Turkey (Türkiye)
View Trial DetailsNCT07667075
Brain Diseases, Central Nervous System Diseases
Haikou, Hainan, China
View Trial Details